Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome
Giancarlo Comi(Vita-Salute San Raffaele University), Massimo Filippi(Vita-Salute San Raffaele University), Vittorio Martinelli(Vita-Salute San Raffaele University), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Mads Ravnborg(Odense University Hospital), Sámuel Komoly(University of Pecs), Adriana Carrá(Hospital Británico de Buenos Aires), Letizia Leocani(Vita-Salute San Raffaele University), Irina Elovaara(Tampere University), Jan Hillert, Catherine Lubetzki(Centre National de la Recherche Scientifique), Franz Fazekas(Medical University of Graz), Daniel Wynn(Consultants in Neurology), Maria A. Rocca(Cognitive Neuroimaging Lab), Paolo Preziosa(Vita-Salute San Raffaele University), Carolyn Young(University of Liverpool), Mariaemma Rodegher(University of Milan), Hans-Peter Hartung(The University of Sydney), Ovidiu Băjenaru(Carol Davila University of Medicine and Pharmacy), John King(The Royal Melbourne Hospital), Kjell-Morten Myhr(Haukeland University Hospital), Lucia Moiola(Vita-Salute San Raffaele University)
Cited by 93
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k